HB3219 99TH GENERAL ASSEMBLY

LRB099 05820 HAF 25864 b

99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
HB3219

Introduced , by Rep. Michael J. Zalewski

SYNOPSIS AS INTRODUCED:

225 ILCS 85/16c new

Amends the Pharmacy Practice Act. Provides that beginning January 1, 2016, the Department of Financial and Professional Regulation shall implement a pilot project requiring that every new or refilled prescription for a Schedule II controlled substance containing hydrocodone shall only be dispensed in a non-reusable medicine locking closure package. Defines "medicine locking closure package" and "Schedule II controlled substance". Provides that the medicine locking closure package must be dispensed by the pharmacy with instructions for patient use. Provides that the manufacturer of the medicine locking closure package must make available assistance online or through a toll-free number for patient use. Provides that prescriptions reimbursed via Medicare Part D and Medicaid and prescriptions for individuals residing in facilities licensed under the Nursing Home Care Act are exempt from the requirements of the pilot project. Repeals the provisions creating the pilot project on January 1, 2017. Effective immediately.

A BILL FOR

AN ACT concerning regulation.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 5. The Pharmacy Practice Act is amended by adding Section 16c as follows:

(225 ILCS 85/16c new)

Sec. 16c. Medicine locking closure package.

(a) As used in this Section:

"Medicine locking closure package" means any alphanumeric combination locking closure mechanism that can only be unlocked with a user-generated, resettable alphanumeric code in combination with an amber prescription container that forms a package that allows only the person with a prescription access to the medicine.

"Schedule II controlled substance" means a Schedule II controlled substance under the United States Controlled Substances Act and 21 CFR 1308.

(b) Effective January 1, 2016, the Department shall implement a pilot project requiring that every new or refilled prescription for a Schedule II controlled substance containing hydrocodone shall only be dispensed in a non-reusable medicine locking closure package.

(c) The medicine locking closure package must be dispensed by the pharmacy with instructions for patient use.

(d) The manufacturer of the medicine locking closure package must make available assistance online or through a toll-free number for patient use.

(e) Prescriptions reimbursed via the Medicare Part D and Medicaid programs, including Medicaid managed care plans, are exempt from the provisions of this Section.

(f) Prescriptions for individuals residing in facilities licensed under the Nursing Home Care Act are exempt from the provisions of this Section.

(g) This Section is repealed on January 1, 2017.

Section 99. Effective date. This Act takes effect upon becoming law.